{"id":4107,"date":"2015-05-27T09:46:58","date_gmt":"2015-05-27T07:46:58","guid":{"rendered":"http:\/\/news.embl.de\/?p=4107"},"modified":"2021-07-13T12:00:27","modified_gmt":"2021-07-13T10:00:27","slug":"1505-elixir-excelerate","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/","title":{"rendered":"ELIXIR accelerates"},"content":{"rendered":"\n<p>EXCELERATE funding will help ELIXIR coordinate and extend national and international data resources to ensure the delivery of world-leading life-science data services. It will support a pan-European training programme, anchored in national infrastructures, to increase bioinformatics capacity and competency. It will also provide efficiencies in management and operation throughout the infrastructure, which is distributed amongst 17 countries.<\/p>\n\n\n\n<p>ELIXIR Director Niklas Blomberg says, \u201cI am delighted that the EU is supporting this high-impact project. In the age of big data, it is critical that we can all make the most of the bioinformatics capacity that has been developed in each of our member states. This will make a difference to Europe&#8217;s 500,000 life-science researchers, who need public research data to be managed well over the long term so it can be reused to maximum effect. EXCELERATE will bring about a step change in how bioinformatics services are coordinated across Europe, ensuring they are integrated, grow in step with the advent of new technologies, and maintained appropriately over the long term.\u201d<\/p>\n\n\n\n<blockquote class=\"vf-blockquote\"><p>This will make a difference to Europe&#8217;s 500,000 life-science researchers, who need public research data to be managed well over the long term<\/p><\/blockquote>\n\n\n\n<p>Dedicated use cases, defined in close partnership with diverse research communities, will help ELIXIR grow in keeping with the needs of scientists working on rare diseases, biomedical and human genomics, marine and plant sciences and other specialized areas. This will ensure that ELIXIR\u2019s services for data, tools, interoperability, compute, training and industry support are rooted in user needs, and can deliver benefits to existing and future research projects.<\/p>\n\n\n<hr class=\"vf-divider\"\/>\n\n\n<h3 class=\"wp-block-heading\">About&nbsp;ELIXIR-EXCELERATE:<\/h3>\n\n\n\n<p>ELIXIR was invited to apply to a dedicated call within Horizon 2020 following the ESFRI and European Council decision in 2014 to categorize ELIXIR as one of <a href=\"https:\/\/www.elixir-europe.org\/news\/elixir-prioritised-esfri\">Europe\u2019s three priority new Research Infrastructures<\/a>. ELIXIR-EXCELERATE represents ELIXIR\u2019s submission to this Call.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ELIXIR receives major Horizon 2020 funding to \u2018EXCELERATE&#8217; activities over the next four years.<\/p>\n","protected":false},"author":16,"featured_media":4111,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[28,782,179,36,25,5686],"embl_taxonomy":[],"class_list":["post-4107","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lab-matters","tag-bioinformatics","tag-database","tag-elixir","tag-embl-ebi","tag-partnerships","tag-rare-disease"],"acf":{"article_intro":"<p>ELIXIR has been awarded \u20ac19 million from the EU to accelerate the implementation of Europe\u2019s life-science data infrastructure over the next four years. From September 2015, \u2018ELIXIR-EXCELERATE\u2019 will facilitate the integration of Europe\u2019s bioinformatics resources, supporting all sectors of life-science R&amp;D. It will deliver excellence to ELIXIR\u2019s users by fast-tracking the development and deployment of essential data services.<\/p>\n","related_links":[{"link_description":"This news item first appeared on the ELIXIR website, 11 May 2015","link_url":"https:\/\/www.elixir-europe.org\/news\/elixir-accelerates-major-horizon-2020-funding"},{"link_description":"ELIXIR \u2013 A distributed infrastructure for life-science information","link_url":"https:\/\/www.elixir-europe.org"}],"article_sources":false,"vf_locked":false,"featured":false,"color":"#007B53","link_color":"#fff","show_featured_image":false,"in_this_article":false,"youtube_url":"","mp4_url":"","video_caption":"","press_contact":"None","translations":false,"embl_taxonomy_term_who":false,"embl_taxonomy_term_what":false,"embl_taxonomy_term_where":false},"embl_taxonomy_terms":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ELIXIR accelerates | EMBL<\/title>\n<meta name=\"description\" content=\"ELIXIR receives major Horizon 2020 funding to \u2018EXCELERATE&#039; activities over the next four years.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ELIXIR accelerates | EMBL\" \/>\n<meta property=\"og:description\" content=\"ELIXIR receives major Horizon 2020 funding to \u2018EXCELERATE&#039; activities over the next four years.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-05-27T07:46:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-13T10:00:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2015\/05\/EXELERATE_website_EMBL.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"425\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Guest author(s)\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Guest author(s)\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/\"},\"author\":{\"name\":\"Guest author(s)\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b\"},\"headline\":\"ELIXIR accelerates\",\"datePublished\":\"2015-05-27T07:46:58+00:00\",\"dateModified\":\"2021-07-13T10:00:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/\"},\"wordCount\":305,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2015\/05\/EXELERATE_website_EMBL.jpg\",\"keywords\":[\"bioinformatics\",\"database\",\"elixir\",\"embl-ebi\",\"partnerships\",\"rare disease\"],\"articleSection\":[\"Lab Matters\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/\",\"url\":\"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/\",\"name\":\"ELIXIR accelerates | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2015\/05\/EXELERATE_website_EMBL.jpg\",\"datePublished\":\"2015-05-27T07:46:58+00:00\",\"dateModified\":\"2021-07-13T10:00:27+00:00\",\"description\":\"ELIXIR receives major Horizon 2020 funding to \u2018EXCELERATE' activities over the next four years.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2015\/05\/EXELERATE_website_EMBL.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2015\/05\/EXELERATE_website_EMBL.jpg\",\"width\":620,\"height\":425},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b\",\"name\":\"Guest author(s)\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g\",\"caption\":\"Guest author(s)\"},\"description\":\"Guest author(s)\",\"url\":\"https:\/\/www.embl.org\/news\/author\/guest-author\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ELIXIR accelerates | EMBL","description":"ELIXIR receives major Horizon 2020 funding to \u2018EXCELERATE' activities over the next four years.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/","og_locale":"en_US","og_type":"article","og_title":"ELIXIR accelerates | EMBL","og_description":"ELIXIR receives major Horizon 2020 funding to \u2018EXCELERATE' activities over the next four years.","og_url":"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2015-05-27T07:46:58+00:00","article_modified_time":"2021-07-13T10:00:27+00:00","og_image":[{"width":620,"height":425,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2015\/05\/EXELERATE_website_EMBL.jpg","type":"image\/jpeg"}],"author":"Guest author(s)","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Guest author(s)","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/"},"author":{"name":"Guest author(s)","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b"},"headline":"ELIXIR accelerates","datePublished":"2015-05-27T07:46:58+00:00","dateModified":"2021-07-13T10:00:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/"},"wordCount":305,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2015\/05\/EXELERATE_website_EMBL.jpg","keywords":["bioinformatics","database","elixir","embl-ebi","partnerships","rare disease"],"articleSection":["Lab Matters"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/","url":"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/","name":"ELIXIR accelerates | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2015\/05\/EXELERATE_website_EMBL.jpg","datePublished":"2015-05-27T07:46:58+00:00","dateModified":"2021-07-13T10:00:27+00:00","description":"ELIXIR receives major Horizon 2020 funding to \u2018EXCELERATE' activities over the next four years.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/lab-matters\/1505-elixir-excelerate\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2015\/05\/EXELERATE_website_EMBL.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2015\/05\/EXELERATE_website_EMBL.jpg","width":620,"height":425},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b","name":"Guest author(s)","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g","caption":"Guest author(s)"},"description":"Guest author(s)","url":"https:\/\/www.embl.org\/news\/author\/guest-author\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2015\/05\/EXELERATE_website_EMBL.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2015\/05\/EXELERATE_website_EMBL.jpg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/4107","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=4107"}],"version-history":[{"count":8,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/4107\/revisions"}],"predecessor-version":[{"id":20669,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/4107\/revisions\/20669"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/4111"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=4107"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=4107"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=4107"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=4107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}